Strategies for craniofacial tissue engineering: innovations for scalable bone regeneration

Abstract

Craniofacial tissue engineering offers promising solutions for addressing large bone defects caused by congenital abnormalities, trauma, or disease. Traditional approaches, such as autografts and synthetic materials, are widely used but face limitations, including donor site morbidity, immune rejection, and poor graft integration. Recent advancements in biomaterials, including nanoscale scaffold design, bioceramics, cell-laden hydrogels, and bioactive modifications, present promising strategies to replicate the biological, mechanical, and structural properties of native bone. This review explores innovative strategies to enhance osteoconductivity, osteoinductivity, and osteogenicity of engineered grafts, including the use of advanced biomaterials, immunomodulatory scaffolds, and bioprinting technologies. Key biological challenges are discussed alongside translational barriers. Future directions emphasize the integration of bioprinted, vascularized, multiphasic tissues, alongside personalized therapies and advanced fabrication techniques, to accelerate clinical adoption. By bridging nanoscale innovations with the demands of large-scale clinical application, this review outlines pathways toward scalable, personalized, and clinically effective solutions to restore functionality and aesthetics in craniofacial reconstruction.